Abdullah KM, Udoh EA, Shewen PE and Mellors A (1992). A neutral glycoprotease of Pasteurella haemolytica A1 specifically cleaves O-sialoglycoproteins. Infection and Immunity 60: 56–62.
Ambagala TC, Ambagala AP & Srikumaran S (1999). The leukotoxin of Pasteurella haemolytica binds to beta(2) integrins on bovine leukocytes. FEMS Microbiology Letters 179: 161–167.
Ames TR (1997). Dairy calf pneumonia. The disease and its impact. Veterinary Clinics of North America Food Animal Practice 13: 379–391.
Ames TR, Markham RJF, Asibo-Opuda J.J Leininger JR & Maheswaran SK (1985). Pulmonary response to intratracheal challenge with Pasteurella haemolytica and Pasteurella multocida. Canadian Journal of Comparative Medicine 49: 395–400.
Baluyut CS, Simonson RR, Bemrick WJ and Maheswaran SK (1981). Interaction of Pasteurella haemolytica with bovine neutrophils: identification and partial characterization of a cytotoxin. American Journal of Veterinary Research 42: 1920–1926.
Berggren KA, Baluyut CS, Simonson RR, Bemrick WJ and Maheswaran SK (1981). The cytotoxic effects of Pasteurella haemolytica. American Journal of Veterinary Research 42: 1383–1388.
Bhakdi S, Mackman N, Nicaud JM and Holland IB (1986). Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores. Infection and Immunity 52: 63–69.
Brown JF, Leite F and Czuprynski CJ (1997). Binding of Pasteurella haemolytica leukotoxin to bovine leukocytes. Infection and Immunity 65: 3719–3724.
Burrows LL, Olah-Winfield E and Lo RY (1993). Molecular analysis of the leukotoxin determinants from Pasteurella haemolytica serotypes 1 to 16. Infection and Immunity 61: 5001–5007.
Chang YF, Young R, Moulds TL and Struck DK (1989). Secretion of the Pasteurella leukotoxin by Escherichia coli. FEMS Microbiology Letters 51: 169–173.
Chang YF, Ma DP, Shi J and Chengappa MM (1993). Molecular characterization of a leukotoxin gene from a Pasteurella haemolytica-like organism, encoding a new member of the RTX toxin family. Infection and Immunity 61: 2089–2095.
Clinkenbeard KD and Upton ML (1991). Lysis of bovine platelets by Pasteurella haemolytica leukotoxin. American Journal of Veterinary Research 52: 453–457.
Clinkenbeard KD, Mosier DA andConfer AW (1989). Transmembrane pore size and role of cell swelling in cytotoxicity caused by Pasteurella haemolytica leukotoxin. Infection and Immunity 57: 420–425.
Clinkenbeard KD, Clark CR, Morton RJ, Panciera RJ, Mosier DA and Confer AW (1992). Role of Pasteurella haemolytica leukotoxin in the virulence and immunity in shipping fever pneumonia. Compendium on Continuing Education for the Practicing Veterinarian 14: 1249–1262.
Clinkenbeard KD, Clark CR, Hague CM, Clinkenbeard P, Srikumaran S and Morton RJ (1994) Pasteurella haemolytica leukotoxin-induced synthesis of eicosanoids by bovine neutrophils in vitro. Journal of Leukocyte Biology 56: 644–649.
Confer AW, Panciera RJ and Mosier DA (1988). Bovine pneumonic pasteurellosis: immunity to Pasteurella haemolytica. Journal of American Veterinary Medical Association 193: 1308–1313.
Confer AW, Simons KR, Panciera RJ, Mort AJ and Mosier DA (1989). Serum antibody response to carbohydrate antigens of Pasteurella haemolytica serotype 1: relation to experimentally induced bovine pneumonic pasteurellosis. American Journal of Veterinary Research 50: 98–105.
Confer AW, Panciera RJ, Clinkenbeard KD and Mosier DA (1990). Molecular aspects of virulence of Pasteurella haemolytica. Canadian Journal of Veterinary Research 54: S48–S52.
Conlon PD, Schewan PE, Donnelly SF and Burger JP (1990). Effects of Pasteurella haemolytica A1 culture supernatant on mechanisms controlling bovine alveolar macrophage oxygen radical production. Canadian Journal of Veterinary Research 54: 232–237.
Conlon JAR, Shewan PE and Lo RYC (1991). Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica. A1. Infection and Immunity 59: 587–591.
Coote JG (1992). Structural and functional relationships among RTX toxin determinants of Gram-negative bacteria. FEMS Microbiology Reviews 88: 137–162.
Cortajarena AL, Goni FM & Ostolaza H (2001). Glycophorin as a receptor for Escherichia coli alpha-hemolysin in erythrocytes. Journal of Biological Chemistry 276: 12513–12519.
Cruz WT, Young R, Chang YF and Struck DK (1990). Deletion analysis resolves cell-binding and lytic domains of the Pasteurella leukotoxin. Molecular Microbiology 4: 1933–1939.
Cudd L, Clarke C, Clinkenbeard K, Shelton M, Clinkenbeard P and Murphy G (1999). Role of intracellular calcium in Pasteurella haemolytica leukotoxin-induced bovine neutrophil leukotriene B4 production and plasma membrane damage. FEMS Microbiology Letters 172: 123–129.
Czuprynski CJ, Hamilton HL and Noel EJ (1987). Ingestion and killing of Pasteurella haemolytica A1 by bovine neutrophils in vitro. Veterinary Microbiology 14: 61–74.
Czuprynski CJ, Noel EJ and Adlam C (1989). Modulation of bovine neutrophil antibacterial activities by Pasteurella haemolytica A1 purified capsular polysaccharide. Microbial Pathogenesis 6: 1 33–41.
Czuprynski CJ, Noel EF, Ortiz-Carranza O and Srikumaran S (1991). Activation of bovine neutrophils by partially purified Pasteurella haemolytica leukotoxin. Infection and Immunity 59: 3126–3133.
Davies RL, Arkinsaw S and Selander RK (1997). Evolutionary genetics of Pasteurella haemolytica isolates recovered from cattle and sheep. Infection and Immunity 65: 3585–3593.
Davies RL, Whittam TS and Selander RK (2001). Sequence diversity and molecular evolution of the leukotoxin (lktA) gene in bovine and ovine strains of Mannheimia (Pasteurella) haemolytica. Journal of Bacteriology 183: 1394–1404.
Davies RL, Campbell S and Whittam TS (2002). Mosaic structure and molecular evolution of the leukotoxin operon (lktCABD) in Mannheimia (Pasteurella) haemolytica, Mannheimia glucosida, and Pasteurella trehalosi. Journal of Bacteriology 184: 266–277.
Deneer HG and Potter AA (1989). Iron-repressible outer-membrane proteins of Pasteurella haemolytica. Journal of General Microbiology 135: 435–443.
Deshpande MS, Ambagala TC, Ambagala AP, Kehrli ME and Srikumaran S (2002). Bovine CD 18 is necessary and sufficient to mediate Mannheimia (Pasteurella) haemolytica leukotoxin-induced cytolysis. Infection and Immunity 70: 5058–5064.
Dyer RM (1982). The bovine respiratory disease complex: a complex interaction of host, environment and infectious factors. Compendium on Continuing Education for the Practicing Veterinarian 4: S296–S304.
Fedorova ND and Highlander SK (1997). Generation of targeted nonpolar gene insertions and operon fusions in Pasteurella haemolytica and creation of a strain that produces and secretes inactive leukotoxin. Infection and Immunity 65: 2593–2598.
Flaherty SF, Golenbock DT, Milham FH and Ingalls RR (1997). CD11/CD18 leukocyte integrins: new signaling receptors for bacterial endotoxin. Journal of Surgical Research 73: 85–89.
Gentry MJ, Confer AW and Panciera RJ (1985). Serum neutralization of cytotoxin from Pasteurella haemolytica ST1 and resistance to experimental bovine pneumonic pasteurellosis. Veterinary Immunology and Immunopathology 9: 239–250.
Gentry MJ, Confer AW, Weinberg ED and Homer JT (1986). Cytotoxin (leukotoxin) production by Pasteurella haemolytica: requirement for an iron-containing compound. American Journal of Veterinary Research 47: 1919–1923.
Gentschev I and Goebel W (1992). Topological and functional studies on HlyB of Escherichia coli. Molecular and General Genetics 232: 40–48.
Gerbig DF, Walker RD, Baker JC, Foster JS and Moore RN (1989). Calcium ion involvement in the action of Pasteurella haemolytica leukotoxin. Veterinary Microbiology 19: 325–335.
Gonzalez C and Maheswaran SK (1993). The role of induced virulence factors produced by Pasteurella haemolytica in the pathogenesis of bovine pneumonic pasteurellosis: review and hypothesis. British Veterinary Journal 149: 183–193.
Gonzalez CT, Maheswaran SK and Murtaugh MP (1995). Pasteurella haemolytica serotype 2 contains the gene for a noncapsular serotype 1-specific antigen. Infection and Immunity 63: 1340–1348.
Griffin D (1997). Economic impact associated with respiratory disease in beef cattle. Veterinary Clinics of North America Food Animal Practice 13: 367–377.
Henricks PAJ, Binkghorst GJ, Drijver AA and Nijkamp FP (1992). Pasteurella haemolytica leukotoxin enhances production of leukotriene B4 and 5-hydroxyeicosatetraenoic acid by bovine polymorphonuclear leukocytes. Infection and Immunity 60: 3238–3243.
Highlander SK, Chidambaram M, Engler MJ and Weinstock GM (1989). DNA sequence of the Pasteurella haemolytica leukotoxin gene cluster. DNA 8: 15–28.
Highlander SK, Fedorova ND, Dusek DM, Panciera R, Alvarez LE and Rinehart C (2000). Inactivation of Pasteurella (Mannheimia) haemolytica leukotoxin causes partial attenuation of virulence in a calf challenge model. Infection and Immunity 68: 3916–3922.
Hormozi K, Parton R and Coote J (1998). Target cell specificity of the Pasteurella haemolytica leukotoxin is unaffected by the nature of the fatty-acyl group used to activate the toxin in vitro. FEMS Microbiology Letters 169: 139–145.
Hsuan SL, Kannan MS, Jeyaseelan S, Prakash YS, Sieck GC and Maheswaran SK (1998). Pasteurella haemolytica A1-derived leukotoxin and endotoxin induce intracellular calcium elevation in bovine alveolar macrophages by different signaling pathways. Infection and Immunity 66: 2836–2844.
Hsuan SL, Kannan MS, Jeyaseelan S, Prakash YS, Malazdrewich C, Abrahamsen MS, Sieck GC and Maheswaran SK (1999). Pasteurella haemolytica leukotoxin and endotoxin induced cytokine gene expression in bovine alveolar macrophages requires NF-kB activation and intracellular calcium elevation. Microbial Pathogenesis 26: 263–273.
Iovane G, Galdiero M, Vitiello M and De Martino L (1998). Effect of Pasteurella haemolytica outer membrane proteins on bovine neutrophils. FEMS Immunology and Medical Microbiology 20: 29–36.
Iwase M, Lally ET, Berthold P, Korchak HM and Taichman NS (1990). Effects of cations and osmotic protectants on cytolytic activity of Actinobacillus actinomycetemcomitans leukotoxin. Infection and Immunity 58: 1782–1788.
Jaramillo L, Diaz F, Hernandez P, Debray H, Trigo F, Mendoza G and Zenteno E (2000). Purification and characterization of an adhesin from Pasteurella haemolytica. Glycobiology 10: 31–37.
Jeyaseelan S, Hsuan SL, Kannan MS, Walcheck B, Wang JF, Kehrli ME, Lally ET, Sieck GC and Maheswaran SK (2000). Lymphocyte function-associated antigen 1 is a receptor for Pasteurella haemolytica leukotoxin in bovine leukocytes. Infection and Immunity 68: 72–79.
Jeyaseelan S, Kannan MS, Briggs RE, Thumbikat P and Maheswaran SK (2001). Mannheimia haemolytica leukotoxin activates a nonreceptor tyrosine kinase signaling cascade in bovine leukocytes, which induces biological effects. Infection and Immunity 69: 6131–6139.
Jeyaseelan S, Kannan MS, Hsuan SL, Singh AK, Walseth TF and Maheswaran SK (2001). Pasteurella (Mannheimia) haemolytica leukotoxin-induced cytolysis of bovine leukocytes: role of arachidonic acid and its regulation. Microbial Pathogenesis 30: 59–69.
Kaehler KL, Markham RJ, Muscoplat CE and Johnson DW (1980). Evidence of species specificity in the cytocidal effects of Pasteurella haemolytica. Infection and Immunity 30: 615–616.
Kitchens RL (2000). Role of CD14 in cellular recognition of bacterial lipopolysaccharides. Chemical Immunology 74: 61–82.
Koronakis V and Hughes C (1996). Synthesis, maturation and export of the E. coli hemolysin. Medical Microbiology and Immunology 185: 65–71.
Koronakis V, Cross M and Hughes C (1989). Transcription anti-termination in an Escherichia coli haemolysin operon is directed progressively by cis-acting DNA sequences upstream of the promoter region. Molecular Microbiology 3: 1397–1404.
Koronakis V, Hughes C and Koronakis E (1993). ATPase activity and ATP/ADP-induced conformational change in the soluble domain of the bacterial protein translocator HlyB. Molecular Microbiology 8: 1163–1175.
Koronakis E, Hughes C, Milisav I and Koronakis V (1995). Protein exporter function and in vitro ATPase activity are correlated in ABC-domain mutants of HlyB. Molecular Microbiology 16: 87–96.
Koronakis V, Li J, Koronakis E and Stauffer K (1997). Structure of TolC, the outer membrane component of the bacterial type I efflux system, derived from two-dimensional crystals. Molecular Microbiology 23: 617–626.
Lafleur RL, Abrahamsen MS and Maheswaran SK (1998). The biphasic mRNA expression pattern of bovine interleukin-8 in Pasteurella haemolytica lipopolysaccharide-stimulated alveolar macrophages is primarily due to tumor necrosis factor alpha. Infection and Immunity 66: 4087–4092.
Lafleur RL, Maladzrewich C, Jeyaseelan S, Bleifield E, Abrahamsen MS and Maheswaran SK (2001). Lipopolysaccharide enhances cytolysis and inflammatory cytokine induction in bovine alveolar macrophages exposed to Mannheimia haemolytica leukotoxin. Microbial Pathogenesis 30: 347–357.
Lally ET, Golub EE and Kieba IR (1994). Identification and immunological characterization of the domain of Actinobacillus actinomycetemcomitans leukotoxin that determines its specificity for human target cells. Journal of Biological Chemistry 269: 31289–31295.
Lally ET, Kieba IR, Sato A, Green CL, Rosenbloom J, Korostoff J, Wang JF, Shenker BJ, Ortlepp S, Robinson MK and Billings PC (1997). RTX toxins recognize a b2 integrin on the surface of human target cells. Journal of Biological Chemistry 272: 30463–30469.
Lalonde G, McDonald TV, Gardner P and O'Hanley PD (1989). Identification of a hemolysin from Actinobacillus pleuropneumoniae and characterization of its channel properties in planar phospholipid bilayers. Journal of Biological Chemistry 264: 13559–13564.
Leite F, Brown JF, Sylte MJ, Briggs RE and Czuprynski CJ (2000). Recombinant bovine interleukin-1beta amplifies the effects of partially purified Pasteurella haemolytica leukotoxin on bovine neutrophils in a beta(2)-integrin-dependent manner. Infection and Immunity 68: 5581–5586.
Leite F, Sylte MJ, O'Brien S, Schultz R, Peek S, van Reeth K and Czuprynski CJ (2001). Effect of experimental infection of cattle with bovine herpesvirus-1 (BHV-1) on the ex vivo interaction of bovine leukocytes with Mannheimia (Pasteurella) haemolytica leukotoxin. Veterinary Immunology and Immunopathology 84: 97–110.
Li J and Clinkenbeard KD (1999). Lipopolysaccharide complexes with Pasteurella haemolytica leukotoxin. Infection and Immunity 67: 2920–2927.
Li J, Clinkenbeard KD and Ritchey JW (1999). Bovine CD 18 identified as a species-specific receptor for Pasteurella haemolytica leukotoxin. Veterinary Microbiology 67: 91–97.
Lillie LE (1974). The bovine respiratory disease complex. Canadian Veterinary Journal 15: 233–242.
Lo RY, Strathdee CA and Shewen PE (1987). Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1. Infection and Immunity 55: 1987–1996.
Lo RY (1990). Molecular characterization of cytotoxins produced by Haemophilus, Actinobacillus, Pasteurella. Canadian Journal of Veterinary Research 54: S33–S35.
Ludwig A, Schmid R, Benz R and Goebel W (1991). Mutations affecting pore formation by haemolysin from Escherichia coli. Molecular and General Genetics 226: 198–208.
Ludwig A, Garcia F, Bauer S, Jarchau T, Benz R, Hoppe J and Goebel W (1996). Analysis of the in vivo activation of hemolysin (HlyA) from Escherichia coli. Journal of Bacteriology 178: 5422–5430.
Mahasreshti PJ, Murphy GL, Wyckoff JH, Farmer S, Hancock RE and Confer AW (1997). Purification and partial characterization of the OmpA family of proteins of Pasteurella haemolytica. Infection and Immunity 65: 211–218.
Maheswaran SK, Berggren KA, Simonson RR, Ward GE and Muscoplat CC (1980). Kinetics of interaction and fate of Pasteurella haemolytica in bovine macrophages. Infection and Immunity 30: 254–262.
Maheswaran SK, Weiss DJ, Kannan MS, Townsend EL, Reddy KR, Whiteley LO and Srikumaran S (1992). Effects of Pasteurella haemolytica A1 leukotoxin on bovine neutrophils: degranulation and generation of oxygen-derived free radicals. Veterinary Immunology and Immunopathology 33: 51–68.
Maheswaran SK, Kannan MS, Weiss DJ, Reddy KR, Townsend EL, Yoo HS, Lee BW and Whiteley LO (1993). Enhancement of neutrophil-mediated injury to bovine pulmonary endothelial cells by Pasteurella haemolytica leukotoxin. Infection and Immunity 61: 2618–2625.
Marciel AM and Highlander SK (2002). Use of operon fusions in Mannheimia haemolytica to identify environmental and cis-acting regulators of leukotoxin transcription. Infection and Immunity 69: 6231–6239.
McVey DS, Loan RW, Purdy CW and Shuman WJ (1990). Specificity of bovine serum antibody to capsular carbohydrate antigens from Pasteurella haemolytica. Journal of Clinical Microbiology 28: 1151–1158.
Medzhitov R, Preston-Hurlburt P and Janeway CA Jr (1997). A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394–397.
Milligan TW, Baker CJ, Straus DC and Mattingly SJ (1978). Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infection and Immunity 21: 738–746.
Morck DW, Raybould TJ, Acres SD, Babiuk LA, Nelligan J and Costerton JW (1987). Electron microscopic description of glycocalyx and fimbriae on the surface of Pasteurella haemolytica-A1. Canadian Journal of Veterinary Research 51: 83–88.
Morck DW, Watts TC, Acres SD and Costerton JW (1988). Electron microscopic examination of cells of Pasteurella haemolytica A1 in experimentally infected cattle. Canadian Journal of Veterinary Research 53: 343–348.
Morck DW, Ellis BD, Domingue PA, Olson ME and Costerton JW (1991). In vivo expression of iron regulated outer-membrane proteins in Pasteurella haemolytica-A1. Microbial Pathogenesis 11: 373–378.
Morton RJ, Panciera RJ, Fulton RW, Frank GH, Ewing SA, Homer JT and Confer AW (1995). Vaccination of cattle with outer membrane protein-enriched fractions of Pasteurella haemolytica and resistance against experimental challenge exposure. American Journal of Veterinary Research 56: 875–879.
Mosier DA (1997). Bacterial pneumonia. Veterinary Clinics of North America Food Animal Practice 13: 483–493.
Mosier DA, Simons KR, Confer AW, Panciera RJ and Clinkenbeard KD (1989). Pasteurella haemolytica antigens associated with resistance to pneumonic pasteurellosis. Infection and Immunity 57: 711–716.
Pandher K and Murphy GL (1996). Genetic and immunological analyses of a 38 kDa surface-exposed lipoprotein of Pasteurella haemolytica A1. Veterinary Microbiology 51: 331–341.
Paulsen DB, Confer AW, Clinkenbeard KD and Mosier DA (1990). Pasteurella haemolytica lipopolysaccharide-induced arachidonic acid release from and neutrophil adherence to bovine pulmonary artery endothelial cells. American Journal of Veterinary Research 51: 1635–1639.
Pellett S and Welch RA (1996). Escherichia coli hemolysin mutants with altered target cell specificity. Infection and Immunity 64: 3081–3087.
Potter AA, Ready K and Gilchrist J (1988). Purification of fimbriae from Pasteurella haemolytica A-1. Microbial Pathogenesis 4: 311–316.
Saadati M, Gibbs HA, Parton R and Coote JG (1997). Characterisation of the leukotoxin produced by different strains of Pasteurella haemolytica. Journal of Medical Microbiology 46: 276–284.
Saban R, Broadstone RV, Haak-Frendscho M, Skoyen S, Fialkowski J, Maheswaran SK, Bjorling DE and Czuprynski C (1997). Effects of Pasteurella haemolytica leukotoxin and lipopolysaccharide on histamine, prostanoid and leukotriene release by bovine lung parenchyma in vitro. American Journal of Veterinary Research 58: 1227–1231.
Schulein R, Gentschev I, Mollenkopf HJ and Goebel W (1992). A topological model for the haemolysin translocator protein HlyD. Molecular and General Genetics 234: 155–163.
Shanley TP, Warner RL and Ward PA (1995). The role of cytokines and adhesion molecules in the development of inflammatory injury. Molecular Medicine Today 1: 40–45.
Shenker BJ, Vitale LA, Keiba I, Harrison G, Berthold P, Golub E and Lally ET (1994). Flow cytometric analysis of the cytotoxic effects of Actinobacillus actinomycetemcomitans leukotoxin on human natural killer cells. Journal of Leukocyte Biology 55: 153–160.
Shewen PE and Wilkie BN (1982). Cytotoxin of Pasteurella haemolytica acting on bovine leukocytes. Infection and Immunity 35: 91–94.
Shewen PE and Wilkie BN (1983). Pasteurella haemolytica cytotoxin: production by recognized serotypes and neutralization by type-specific rabbit antisera. American Journal of Veterinary Research 44: 715–719.
Shewen PE and Wilkie BN (1985). Evidence for the Pasteurella haemolytica cytotoxin as a product of actively growing bacteria. American Journal of Veterinary Research 46: 1212–1214.
Soloaga A, Veiga MP, Garcia-Segura LM, Ostolaza H, Brasseur R and Goni FM (1999). Insertion of Escherichia coli alpha-haemolysin in lipid bilayers as a non-transmembrane integral protein: prediction and experiment. Molecular Microbiology 31: 1013–1024.
Sreevatsan S, Ames TR, Werdin RE, Yoo HS and Maheswaran SK (1996). Evaluation of three experimental subunit vaccines against pneumonic pasteurellosis in cattle. Vaccine 14: 147–155.
Srinand S, Hsuan SL, Yoo HS, Maheswaran SK, Ames TR and Werdin RE (1996). Comparative evaluation of antibodies induced by commercial Pasteurella haemolytica vaccines using solid phase immunoassays. Veterinary Microbiology 49: 181–195.
Srinand S, Maheswaran SK, Ames TR, Werdin RE and Hsuan SL (1996). Evaluation of efficacy of three commercial vaccines against experimental bovine pneumonic pasteurellosis. Veterinary Microbiology 52: 81–89.
Stanley P, Koronakis V and Hughes C (1991). Mutational analysis supports a role for multiple structural features in the C-terminal secretion signal of Escherichia coli haemolysin. Molecular Microbiology 5: 2391–2403.
Stanley P, Koronakis V and Hughes C (1998). Acylation of Escherichia coli hemolysin: a unique protein lipidation mechanism underlying toxin function. Microbiology and Molecular Biology Reviews 62: 309–333.
Stevens P and Czuprynski CJ (1995). Dissociation of cytolysis and monokine release by bovine mononuclear phagocytes incubated with Pasteurella haemolytica partially purified leukotoxin and lipopolysaccharide. Canadian Journal of Veterinary Research 59: 110–117.
Stevens P and Czuprynski CJ (1996). Pasteurella haemolytica leukotoxin induces bovine leukocytes to undergo morphologic changes consistent with apoptosis in vitro. Infection and Immunity 64: 2687–2694.
Strathdee CA and Lo EY (1981). Extensive homology between the leukotoxin of Pasteurella haemolytica AI and the a-hemolysin of Escherichia coli. Infection and Immunity 55: 3233–3236.
Strathdee CA and Lo RY (1989). Cloning, nucleotide sequence, and characterization of genes encoding the secretion function of the Pasteurella haemolytica leukotoxin determinant. Journal of Bacteriology 171: 916–928.
Strathdee CA and Lo RY (1989). Regulation of expression of the Pasteurella haemolytica leukotoxin determinant. Journal of Bacteriology 171: 5955–5962.
Sun Y, Clinkenbeard KD, Cudd LA, Clarke CR and Clinkenbeard PA (1999). Correlation of Pasteurella haemolytica leukotoxin binding with susceptibility to intoxication of lymphoid cells from various species. Infection and Immunity 67: 6264–6269.
Sutherland AD (1985). Effects of Pasteurella haemolytica cytotoxin on ovine peripheral blood leucocytes and lymphocytes obtained from gastric lymph. Veterinary Microbiology 10: 431–438.
Taichman NS, Simpson DL, Sakurada S, Cranfield M, DiRienzo J and Slots J (1987). Comparative studies on the biology of Actinobacillus actinomycetemcomitans leukotoxin in primates. Oral Microbiology and Immunology 2: 97–104.
Tapping RI and Tobias PS (2000). Soluble CD 14-mediated cellular responses to lipopolysaccharide. Chemical Immunology 74: 108–121.
Tatum FM, Briggs RE, Srinand S, Zehr ES, Hsuan SL, Whiteley LO, Ames TR and Maheswaran SK (1998). Construction of an isogenic leukotoxin deletion mutant of Pasteurella haemolytica serotype 1: characterization and virulence. Microbial Pathogenesis 24: 37–46.
Thanabalu T, Koronakis E, Hughes C and Koronakis V (1998). Substrate-induced assembly of a contiguous channel for protein export from E.coli: reversible bridging of an inner-membrane translocase to an outer membrane exit pore. EMBO Journal 17: 6487–6496.
Ulevitch RJ and Tobias PS (1995). Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annual Review of Immunology 13: 437–457.
Wang JF, Kieba IR, Korostoff J, Guo TL, Yamaguchi N, Rozmiarek H, Billings PC, Shenker BJ and Lally ET (1998). Molecular and biochemical mechanisms of Pasteurella haemolytica leukotoxin-induced cell death. Microbial Pathogenesis 25: 317–331.
Wang Z, Clarke C and Clinkenbeard K (1998). Pasteurella haemolytica leukotoxin-induced increase in phospholipase A2 activity in bovine neutrophils. Infection and Immunity 66: 1885–1890.
Welch RA (1991). Pore-forming cytolysins of Gram-negative bacteria. Molecular Microbiology 5: 521–528.
Welch RA, Bauer ME, Kent AD, Leeds JA, Moayeri M, Regassa LB and Swenson DL (1995). Battling against host phagocytes: the wherefore of the RTX family of toxins. Infectious Agents and Diseases 4: 254–272.
Westrop G, Hormozi K, da Costa N, Parton R and Coote J (1997). Structure–function studies of the adenylate cyclase toxin of Bordetella pertussis and the leukotoxin of Pasteurella haemolytica by heterologous C protein activation and construction of hybrid proteins. Journal of Bacteriology 179: 871–879.
Whiteley LO, Maheswaran SK, Weiss DJ and Kannan MS (1992). Pasteurella haemolytica A1 and bovine respiratory disease: pathogenesis. Journal of Veterinary Internal Medicine 6: 11–22.
Wikse SE (1985). Feedlot cattle pneumonia. Veterinary Clinics of North America Food Animal Practice 1: 289–310.
Wohlgemuth K and Herrick JB (1987). Bovine respiratory disease: an overview of costs, causes, and control. Norden News 62: 32–36.
Yoo HS, Maheswaran SK, Lin G, Townsend EL and Ames TR (1995). Induction of inflammatory cytokines in bovine alveolar macrophages following stimulation with Pasteurella haemolytica lipopolysaccharide. Infection and Immunity 63: 381–388.
Yoo HS, Rajagopal BS, Maheswaran SK and Ames TR (1995). Purified Pasteurella haemolytica leukotoxin induce expression of inflammatory cytokines from bovine alveolar macrophages. Microbial Pathogenesis 18: 237–254.
Yoo HS, Rutherford MS, Maheswaran SK and Ames TR (1996). Induction of nitric oxide production by bovine alveolar macrophages in response to Pasteurella haemolytica A1. Microbial Pathogenesis 20: 361–375.
Zhang F, Greig DI and Ling V (1993). Functional replacement of the hemolysin A transport signal by a different primary sequence. Proceedings of the National Academy of Sciences of the United States of America 90: 4211–4215.